<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.06 Preauthorization Requirements. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.09/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.09/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|09|03|.06|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="doc-num" content=".06"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|09|03|.06" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.09.03.06"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".06 Preauthorization Requirements. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message">Â </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09" title="Subtitle 09 MEDICAL CARE PROGRAMS">Subtitle 09 MEDICAL CARE PROGRAMS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">Chapter 03 Pharmacy Services</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03|.06" data-search-heading="">
                  <span title=".06 Preauthorization Requirements.">.06 Preauthorization Requirements.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|09|03|.06">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.09.03.06">.06 Preauthorization Requirements.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> The provider shall obtain preauthorization from the Department or its designee for any prescription for:</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> Antibiotic liquids requiring reconstitution for amounts exceeding a 14-day supply;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> Nonmaintenance drugs for more than a 34 day supply;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> A usual and customary charge exceeding $2,500;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(4)">(4)</span> Female hormones for biologic males when used for treating sexual aggression;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(5)">(5)</span> Vitamin and mineral products when given by nasogastric, jejunostomy, or gastrostomy tube in the home;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(6)">(6)</span> Drugs rejected by the point-of-sale system because of edits established by the Program to ensure appropriate utilization of medication before the prescription is dispensed, if the Department does not allow provider level overrides;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(7)">(7)</span> Where a prescriber has filed an official report of an adverse event or product problem with the Program or the United States Food and Drug Administration regarding a generic drug, the brand name drug used as an alternative to that generic drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(8)">(8)</span> Drugs identified by the Program that are subject to fraud or abuse; or</p>
                <p class="text-indent-2 "><span class="level-num" id="A(9)">(9)</span> Drugs not on the preferred drug list developed under <a class="internal-link " href="/us/md/exec/comar/10.09.03.12" title=".12 Preferred Drug Program.">Regulation .12 of this chapter</a> except for:</p>
                <p class="text-indent-3 "><span class="level-num" id="A(9)(a)">(a)</span> Antiretrovirals; or</p>
                <p class="text-indent-3 "><span class="level-num" id="A(9)(b)">(b)</span> Any other drugs or classes of drugs as determined by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Off-Label Uses of Drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(1)">(1)</span> The Department may require preauthorization for an off-label use of a drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(2)">(2)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.09.03.06#B(3)" title="">Â§B(3) of this regulation</a>, the Department or its designee may not grant preauthorization for an off-label use of the drug if:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(a)">(a)</span> The off-label use is inconsistent with generally accepted standards of care;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(b)">(b)</span> The drug is prescribed for a non-medically accepted indication;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(c)">(c)</span> The drug is prescribed in a manner not approved by the U.S. Food and Drug Administration; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(2)(d)">(d)</span> The off-label use is not documented in and supported by the latest edition of:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(d)(i)">(i)</span> The American Hospital Formulary Service Drug Information (AHFS-DI);</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(d)(ii)">(ii)</span> The Thompson Micromedex Drugdex; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(2)(d)(iii)">(iii)</span> The United States Pharmacopeia.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(3)">(3)</span> The Department or its designee may grant preauthorization for the off-label use of mental health drugs for individuals 18 years old and younger within the limits established by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Preauthorization is not required for:</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> Prescriptions for oral contraceptive drug products;</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> Drugs dispensed in unit dose form to patients in a nursing facility by a provider using an approved unit dose system.</p>
                <p class="text-indent-1 "><span class="level-num" id="D">D.</span> Preauthorization Process.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(1)">(1)</span> The provider or the prescriber, if appropriate, ordering a drug subject to preauthorization, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(a)">(a)</span> Contact the Department or its designee through an established 24-hour hot-line to request preauthorization; and</p>
                <p class="text-indent-3 "><span class="level-num" id="D(1)(b)">(b)</span> Provide required information and documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(2)">(2)</span> The Department or its designee shall respond to a request for preauthorization by telephone or facsimile request within 24 hours of receipt of a request for preauthorization.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(3)">(3)</span> A 72-hour supply of the prescribed drug shall be allowed:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(a)">(a)</span> In an emergency as determined by the prescriber;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(b)">(b)</span> In an emergency as determined by the pharmacist, if possible in consultation with the prescriber; or</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(c)">(c)</span> If the Department does not provide a response to a preauthorization request within 24 hours.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(4)">(4)</span> A preauthorization granted by the Department or its designee under this Regulation may not be used by any person as indicating that the individual for whom the prescription was ordered is eligible for Program benefits on the day the prescription is filled or that the Department will guarantee reimbursement for the prescription. All Program restrictions and requirements on eligibility, covered services, and limitations on reimbursement remain in effect.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(5)">(5)</span> A 30-day emergency supply of atypical antipsychotic drugs not on the preferred drug list shall be:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(5)(a)">(a)</span> Immediately authorized by the Department or its designee in an emergency as determined by the:</p>
                <p class="text-indent-4 "><span class="level-num" id="D(5)(a)(i)">(i)</span> Prescriber; or</p>
                <p class="text-indent-4 "><span class="level-num" id="D(5)(a)(ii)">(ii)</span> Pharmacist, if unable to contact the prescriber; and</p>
                <p class="text-indent-3 "><span class="level-num" id="D(5)(b)">(b)</span> Limited to a one-time 30-day period.</p>
                <p class="text-indent-1 "><span class="level-num" id="E">E.</span> Reconsideration of Adverse Decisions.</p>
                <p class="text-indent-2 "><span class="level-num" id="E(1)">(1)</span> The Department or its designee shall respond within 48 hours of receiving all necessary documentation of a written request from a participant or provider for reconsideration of an adverse decision on a preauthorization request.</p>
                <p class="text-indent-2 "><span class="level-num" id="E(2)">(2)</span> The Department or its designee shall ensure that all adverse decisions of reconsiderations are reviewed and issued by a physician.</p>
                <p class="text-indent-2 "><span class="level-num" id="E(3)">(3)</span> Appeals of adverse decisions of reconsideration requests shall be filed in accordance with <a class="internal-link " href="/us/md/exec/comar/10.09.03.10" title=".10 Appeal Procedures.">Regulation .10 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="F">F.</span> The Department or its designee may:</p>
                <p class="text-indent-2 "><span class="level-num" id="F(1)">(1)</span> Require preauthorization for more than ten prescriptions including refills per 30-day period per noninstitutionalized participant; and</p>
                <p class="text-indent-2 "><span class="level-num" id="F(2)">(2)</span> May exclude certain drugs such as antibiotics from the limit as appropriate.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.09.03.05-1" aria-label=".05-1 Expanded Limitations.">
                <div class="h__ui">Previous</div>
                <span>.05-1 Expanded Limitations.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.09.03.07" aria-label=".07 Payment Procedures.">
                <div class="h__ui">Next</div>
                <span>.07 Payment Procedures.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC-BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
